Welcome to our lab at Virginia Tech/Biological Sciences
Oncoproteomics, mass spectrometry and microfluidic technologies
Cancer is a disease of the cell cycle that results in uncontrolled proliferation of cells. In our laboratory, we explore the molecular mechanisms of breast cancer cell cycle regulation by using holistic, mass spectrometry-based systems biology approaches. We develop proteomic technologies for investigating the pathways that enable cancer cells to bypass tightly regulated molecular checkpoints, proliferate in an unrestrained manner, metastasize, and hijack normal biological function. Further, we capitalize on the power of our proteomic data to identify novel therapeutic drug-targets and develop microfluidic architectures for targeted detection of biomarkers indicative of disease.